Interferon Beta-1b Level in Parkinson’s Disease: Before and After SARS-CoV-2 Vaccination
Background: Parkinson’s disease (PD) is a neurodegenerative disease. Immune response varies after vaccination in different patients. We aimed to evaluate interferon beta-1b (IFNβ-1b) level in patients with PD in response to inactivated SARS-CoV-2 (CoronaVac) vaccination. Methods: Eight patients with...
Main Authors: | Yaprak Dönmez Çakıl, Zeynep Güneş Özünal, Sibel Karsıdağ, Şevki Şahin |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2022-01-01
|
Series: | International Clinical Neuroscience Journal |
Subjects: | |
Online Access: | http://journals.sbmu.ac.ir/neuroscience/PDF/icnj-9-e23.pdf |
Similar Items
-
Vasculitis con necrosis digital asociada con interferón beta
by: Evangelina Miretti, et al.
Published: (2013-09-01) -
Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01) -
Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
by: Dian HE, et al.
Published: (2014-09-01) -
Investigating the Occurrence of Femoral Head Avascular Necrosis in Patient with Multiple Sclerosis Treated with Interferon-Beta
by: Pegah Sadat Fatehi, et al.
Published: (2018-11-01) -
Interferon-beta injection site reactions in patients with multiple sclerosis
by: Martina Maurelli, et al.
Published: (2018-11-01)